Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis

Rheumatology International

Volumn 16, Issue 2, 1996, Pages 45-48

  Salvarani, C ^a   Baricchi, R ^b   Lasagni, D ^b   Boiardi, L ^a   Piccinini, R ^c   Brunati, C ^d   Macchioni, P ^a   Portioli, I ^a  

^a Servizio di Reumatologia   (Italy)

^b Ctro Trasfusionale Azienda O   (Italy)

^c USL di Reggio Emilia   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Chronic disease anemia; Desferrioxamine therapy; Erythropoietin; Interleukin 6; Rheumatoid arthritis

Indexed keywords

ANTIANEMIC AGENT; DEFEROXAMINE; ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 6;

ADULT; ANEMIA; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE ACTIVITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RETICULOCYTE COUNT; RHEUMATOID ARTHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029797639     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01816434     Document Type: Article

References (15)

1. Baer AN, Dessypiris EN, Krantz SB (1971) The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum 19:209-223
2. Baer AN, Dessypiris EN, Goldwasser E, Krantz SB (1987) Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 66:559-564
3. Salvarani C, Casali B, Salvo D, Brunati C, Macchioni PL, Massai G, Lasagni D, Rivasi P, Portioli I (1991) The role of interleukin-1, erythropoietin and red cells bound immunoglobulins in the anaemia of rheumatoid arthritis. Clin Exp Rheumatol 9:241-246
4. Salvarani C, Lasagni D, Casali B, Macchioni PL, Boiardi L, Rossi F, Rivasi P, Portioli I (1991) Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anaemia of chronic disease. J Rheumatol 18:1168-1171
5. Pincus T, Olsen NJ, Russell IJ, Wolfe F, Harris RR, Schinitzer TJ, Boccagno JA, Krantz SB (1990) Multicenter study of recombinant human erythropoietin in correction of anaemia in rheumatoid arthritis. Am J Med 89:161-168
6. Faquin WC, Schneider TJ, Goldberg MA (1992) Effects of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79:1987-1994
7. Magaró M, Zoli A, Altomonte L, Mirone L, Corvino G, Storti S, Marra R, Ricerca BM, Pagano L, Dicesare L (1990) Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation. Ann Rheum Dis 49:268-271
8. Giordano N, Sancasciani S, Borghi C, Fioravanti A, Marcolongo R (1986) Antianemic and potential anti-inflammatory activity of desferrioxamine: possible usefulness in rheumatoid arthritis. Clin Exp Rheumatol 4:25-29
9. Vreugdenhil G, Kontoghiorghess GJ, Van Eijk HG, Swaak AJK (1991) Impaired erythropoietin responsiveness to the anaemia in rheumatoid arthritis. A possible inverse relationship with iron stores and effects of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Clin Exp Rheumatol 9:35-40
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
11. Propper RD, Shurin SB, Nathan DG (1976) Reassessment of the use of desferrioxamine B in iron overload. N Engl J Med 294:1421-1423
12. Wang GL, Semenza GL (1993) Desferrioxamine induces erythropoietin gene expression and hypoxia inducible factor 1 DNA binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615
13. Dagupta B, Corkill M, Kirkam B, Gibson T, Panayi G (1992) Serial estimation of interleukin-6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol 19:22-25
14. Polson RJ, Jawed A, Bomford A, Berry H, Williams R (1985) Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects. B M J 291:448
15. Blake DR, Winyard P, Lunec J, Williams A, Good PA, Crewes SJ, Gutteridge JMC, Rowley D, Halliwell B, Cornish A, Hider RC (1985) Cerebral and ocular toxicity induced by desferrioxamine. Q J M 219:345-355